Brief Biographical Sketch

As of January 1, 2012, I have retired from the Canadian Cancer Society (CCS) where I was the inaugural Vice-President, Research (nationally) as well as the first Scientific Director of the recently established Canadian Cancer Society Research Institute (which was formed after the formal integration, in 2009, of the CCS with the former National Cancer Institute of Canada (NCIC)).

In these roles, my mandates included the oversight of all of the Society’s research programs across the country, managing a portfolio of between $40 and $50 Million annually. One of my key roles was the engagement of the public to build both understanding and commitment for cancer research. As a result, I became a much-sought after speaker, because my passion for cancer research showed through in everything I did and presented. I have given talks in all parts of the country and have had an extensive array of media engagements, including television, radio and all print media.

The Blog attached to this website (accessible from the Main Menu or directly if you click here: Cancer Research 101 BLOG) therefore represents a logical extension for me.

After the integration of CCS and NCIC, I oversaw the drafting of a first-ever CCS research strategy as an integral part of the development of an overall CCS strategic plan, which the CCS National Board approved in 2010. To ensure alignment with the new strategic plan, I also oversaw, prior to my retirement, the total redesign of the CCSRI’s research portfolio. With a new strategic plan and a new program in place, however, I decided that this was the perfect time to step down and hand over the reins, allowing me some valued time to take a breather and explore new options. 

The aforementioned Blog, and a related Facebook page (Facebook.com/CancerResearch101) are some of those new explorations.

Prior to my appointment as the VP Research of the Canadian Cancer Society, I proudly served the National Cancer Institute of Canada in two successive capacities. I was the Executive Director of the NCIC for almost 7 years, where I had oversight responsibilities for all areas of NCIC’s activities: Research Programs, Planning and Portfolio Management, Finance, Communications, and Cancer Control Policy. I was intensively involved with the NCIC Board of Directors in developing and  implementing a new Strategic Plan, entitled NCIC 2015: Driving Excellent Research to Improve Cancer Control. 

Before taking over as the Executive Director of the NCIC, I served as its inaugural Director of Research Programs for more than 10 years. Over this decade, I initiated and managed a number of significant changes to the NCIC’s research programs and for the very ways in which NCIC operates. 

Immediately prior to joining the NCIC, I worked at Allelix Biopharmaceuticals Inc. in Toronto from 1983 to 1992 in various research and senior leadership capacities. Most notably, I was the company’s founding Director of Neuroscience Research, leading an international program (Canada, United States, England) on research into human central nervous system receptor signalling. I was a Research Scientist and Group Leader at Toronto’s Connaught Research Institute from 1981-1983, where I did research into biological methods for high-level production of recombinant, human proinsulin for potential human use.

Overall, then, I have almost 35 years of research experience encompassing the academic, biotechnology and not-for-profit sectors. It all started with a BSc degree from the University of Toronto (1974), followed by a PhD degree in molecular biology from Queen’s University in Kingston, Ontario (1978). After my PhD, I did further training as a Post-Doctoral Fellow of the Medical Research Council of Canada, working in the fields of molecular biology and gene expression at the University of Calgary Medical School (1978 – 1981).

Anyone wishing to download my resume can find it on this site (Click Here). If anyone prefers a copy of my full Curriculum vitae, feel free to contact me directly.

 
If you enjoyed this post, please consider sharing it, leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.